First Nebraska Trust Co
- SEC CIK
- 0002134841
- Latest filing
- Aug 12, 2026
PFE holding history
Pfizer Inc in every 13F filed by First Nebraska Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 106,986
- Value
- $2.58M
- % of portfolio
- 0.2%
- Quarters held
- 103
- Since Q2 2000
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 106,986 | $2.58M | 0.2% | +1,218+1.2% | Added | Holders |
| Q1 2026 | 105,768 | $2.97M | 0.3% | +1,510+1.4% | Added | Holders |
| Q4 2025 | 104,258 | $2.60M | 0.2% | +528+0.5% | Added | Holders |
| Q3 2025 | 103,730 | $2.64M | 0.2% | −3,338−3.1% | Reduced | Holders |
| Q2 2025 | 107,068 | $2.60M | 0.2% | −1,931−1.8% | Reduced | Holders |
| Q1 2025 | 108,999 | $2.76M | 0.3% | +20,973+23.8% | Added | Holders |
| Q4 2024 | 88,026 | $2.34M | 0.2% | −53,089−37.6% | Reduced | Holders |
| Q3 2024 | 141,115 | $4.08M | 0.4% | +20,653+17.1% | Added | Holders |
| Q2 2024 | 120,462 | $3.37M | 0.3% | −1,174−1.0% | Reduced | Holders |
| Q1 2024 | 121,636 | $3.38M | 0.3% | −1,195−1.0% | Reduced | Holders |
| Q4 2023 | 122,831 | $3.54M | 0.4% | −30,945−20.1% | Reduced | Holders |
| Q3 2023 | 153,776 | $5.10M | 0.6% | +1,903+1.3% | Added | Holders |
| Q2 2023 | 151,873 | $5.57M | 0.7% | +8,894+6.2% | Added | Holders |
| Q1 2023 | 142,979 | $5.83M | 0.7% | +2,820+2.0% | Added | Holders |
| Q4 2022 | 140,159 | $7.18M | 0.9% | −607−0.4% | Reduced | Holders |
| Q3 2022 | 140,766 | $6.16M | 0.9% | +1,288+0.9% | Added | Holders |
| Q2 2022 | 139,478 | $7.31M | 1.0% | −513−0.4% | Reduced | Holders |
| Q1 2022 | 139,991 | $7.25M | 0.9% | −1,000−0.7% | Reduced | Holders |
| Q4 2021 | 140,991 | $8.33M | 1.0% | −1,289−0.9% | Reduced | Holders |
| Q3 2021 | 142,280 | $6.12M | 0.8% | +175+0.1% | Added | Holders |
| Q2 2021 | 142,105 | $5.56M | 0.7% | +10,176+7.7% | Added | Holders |
| Q1 2021 | 131,929 | $4.78M | 0.6% | – | No prior filing | Holders |
| Q3 2020 | – | – | – | – | Not filed | – |
| Q2 2020 | 114,124 | $3.73M | 0.7% | −933−0.8% | Reduced | – |
| Q1 2020 | 115,057 | $3.76M | 0.8% | +4,923+4.5% | Added | – |
| Q4 2019 | 110,134 | $4.32M | 0.7% | +3,866+3.6% | Added | – |
| Q3 2019 | 106,268 | $3.82M | 0.6% | +11,596+12.2% | Added | – |
| Q2 2019 | 94,672 | $4.10M | 0.7% | +6,193+7.0% | Added | – |
| Q1 2019 | 88,479 | $3.76M | 0.7% | −259−0.3% | Reduced | – |
| Q4 2018 | 88,738 | $3.87M | 0.8% | −402−0.5% | Reduced | – |
| Q3 2018 | 89,140 | $3.93M | 0.7% | −1,197−1.3% | Reduced | – |
| Q2 2018 | 90,337 | $3.28M | 0.7% | −1,106−1.2% | Reduced | – |
| Q1 2018 | 91,443 | $3.25M | 0.6% | +4,850+5.6% | Added | – |
| Q4 2017 | 86,593 | $3.14M | 0.6% | −18,167−17.3% | Reduced | – |
| Q3 2017 | 104,760 | $3.74M | 0.8% | −70−0.1% | Reduced | – |
| Q2 2017 | 104,830 | $3.52M | 0.8% | −1,160−1.1% | Reduced | – |
| Q1 2017 | 105,990 | $3.63M | 0.8% | +12,419+13.3% | Added | – |
| Q4 2016 | 93,571 | $3.04M | 0.7% | +17,402+22.8% | Added | – |
| Q3 2016 | 76,169 | $2.58M | 0.7% | +100+0.1% | Added | – |
| Q2 2016 | 76,069 | $2.68M | 0.7% | +1,395+1.9% | Added | – |
| Q1 2016 | 74,674 | $2.21M | 0.6% | −266−0.4% | Reduced | – |
| Q4 2015 | 74,940 | $2.42M | 0.7% | −1,925−2.5% | Reduced | – |
| Q3 2015 | 76,865 | $2.41M | 0.8% | 00.0% | Unchanged | – |
| Q2 2015 | 76,865 | $2.58M | 0.8% | −2,182−2.8% | Reduced | – |
| Q1 2015 | 79,047 | $2.75M | 0.8% | −383−0.5% | Reduced | – |
| Q4 2014 | 79,430 | $2.47M | 0.7% | −3,466−4.2% | Reduced | – |
| Q3 2014 | 82,896 | $2.45M | 0.7% | −1,700−2.0% | Reduced | – |
| Q2 2014 | 84,596 | $2.51M | 0.7% | −850−1.0% | Reduced | – |
| Q1 2014 | 85,446 | $2.74M | 0.8% | +475+0.6% | Added | – |
| Q4 2013 | 84,971 | $2.60M | 0.8% | −1,550−1.8% | Reduced | – |
| Q3 2013 | 86,521 | $2.49M | 0.9% | +200+0.2% | Added | – |
| Q2 2013 | 86,321 | $2.42M | 0.9% | +700+0.8% | Added | – |
| Q1 2013 | 85,621 | $2.47M | 0.9% | +50+0.1% | Added | – |
| Q4 2012 | 85,571 | $2.15M | 0.9% | −1,200−1.4% | Reduced | – |
| Q3 2012 | 86,771 | $2.16M | 0.9% | +120+0.1% | Added | – |
| Q2 2012 | 86,651 | $1.99M | 0.8% | +1,130+1.3% | Added | – |
| Q1 2012 | 85,521 | $1.94M | 0.8% | +1,529+1.8% | Added | – |
| Q4 2011 | 83,992 | $1.82M | 0.8% | +3,712+4.6% | Added | – |
| Q3 2011 | 80,280 | $1.42M | 0.7% | +150+0.2% | Added | – |
| Q2 2011 | 80,130 | $1.65M | 0.8% | −3,000−3.6% | Reduced | – |
| Q1 2011 | 83,130 | $1.69M | 0.8% | +1,600+2.0% | Added | – |
| Q4 2010 | 81,530 | $1.43M | 0.7% | −1,600−1.9% | Reduced | – |
| Q3 2010 | 83,130 | $1.43M | 0.8% | −3,750−4.3% | Reduced | – |
| Q2 2010 | 86,880 | $1.24M | 0.7% | −50−0.1% | Reduced | – |
| Q1 2010 | 86,930 | $1.49M | 0.8% | −559−0.6% | Reduced | – |
| Q4 2009 | 87,489 | $1.59M | 0.9% | +1,897+2.2% | Added | – |
| Q3 2009 | 85,592 | $1.42M | 0.9% | −913−1.1% | Reduced | – |
| Q2 2009 | 86,505 | $1.30M | 0.9% | −32,000−27.0% | Reduced | – |
| Q1 2009 | 118,505 | $1.61M | 1.2% | +2,700+2.3% | Added | – |
| Q4 2008 | 115,805 | $2.05M | 1.4% | −5,450−4.5% | Reduced | – |
| Q3 2008 | 121,255 | $2.24M | 1.1% | −6,945−5.4% | Reduced | – |
| Q2 2008 | 128,200 | $2.24M | 1.1% | −8,983−6.5% | Reduced | – |
| Q1 2008 | 137,183 | $2.87M | 1.4% | +14,893+12.2% | Added | – |
| Q4 2007 | 122,290 | $2.78M | 1.3% | −18,070−12.9% | Reduced | – |
| Q3 2007 | 140,360 | $3.43M | 1.4% | +950+0.7% | Added | – |
| Q2 2007 | 139,410 | $3.56M | 1.5% | +100+0.1% | Added | – |
| Q1 2007 | 139,310 | $3.52M | 1.5% | +450+0.3% | Added | – |
| Q4 2006 | 138,860 | $3.60M | 1.5% | +18,550+15.4% | Added | – |
| Q3 2006 | 120,310 | $3.41M | 1.5% | +800+0.7% | Added | – |
| Q2 2006 | 119,510 | $2.80M | 1.3% | 00.0% | Unchanged | – |
| Q1 2006 | 119,510 | $2.98M | 1.4% | +4,716+4.1% | Added | – |
| Q4 2005 | 114,794 | $2.68M | 1.3% | −4,228−3.6% | Reduced | – |
| Q3 2005 | 119,022 | $2.97M | 1.4% | −250−0.2% | Reduced | – |
| Q2 2005 | 119,272 | $3.29M | 1.5% | +7,850+7.0% | Added | – |
| Q1 2005 | 111,422 | $2.93M | 1.4% | +15,900+16.6% | Added | – |
| Q4 2004 | 95,522 | $2.57M | 1.1% | −16,300−14.6% | Reduced | – |
| Q3 2004 | 111,822 | $3.42M | 1.7% | +2,700+2.5% | Added | – |
| Q2 2004 | 109,122 | $3.74M | 1.7% | +24,900+29.6% | Added | – |
| Q1 2004 | 84,222 | $2.95M | 1.3% | +8,323+11.0% | Added | – |
| Q4 2003 | 75,899 | $2.68M | 1.3% | +14,150+22.9% | Added | – |
| Q3 2003 | 61,749 | $1.88M | 1.1% | +11,290+22.4% | Added | – |
| Q2 2003 | 50,459 | $1.72M | 1.0% | +11,284+28.8% | Added | – |
| Q1 2003 | 39,175 | $1.22M | 0.9% | +3,153+8.8% | Added | – |
| Q4 2002 | 36,022 | $1.10M | 0.7% | +2,853+8.6% | Added | – |
| Q3 2002 | 33,169 | $962.6K | 0.7% | +200+0.6% | Added | – |
| Q2 2002 | 32,969 | $1.15M | 0.8% | +3,850+13.2% | Added | – |
| Q1 2002 | 29,119 | $1.16M | 0.7% | +675+2.4% | Added | – |
| Q4 2001 | 28,444 | $1.13M | 0.7% | +13,450+89.7% | Added | – |
| Q3 2001 | 14,994 | $601.3K | 0.4% | +4,700+45.7% | Added | – |
| Q2 2001 | 10,294 | $412.3K | 0.3% | +2,250+28.0% | Added | – |
| Q1 2001 | 8,044 | $329.4K | 0.2% | +2,150+36.5% | Added | – |
| Q4 2000 | 5,894 | $271.1K | 0.2% | −183−3.0% | Reduced | – |
| Q3 2000 | 6,077 | $273.1K | 0.2% | −1,100−15.3% | Reduced | – |
| Q2 2000 | 7,177 | $344.5K | 0.3% | – | – | – |
Livermore's 13F data starts with Q2 2000, so Q2 2000 has no change from the previous quarter.